Sickle Cell Disease and the 7.05 Listing

Sickle cell disease qualifies for Social Security Disability Insurance under Blue Book Listing 7.05 when it produces at least six documented pain crises, three qualifying hospitalizations, or repeatedly severe anemia within a 12-month period. The Social Security Administration (SSA) rewrote its hematological listings in final rules published December 1, 2016 (81 FR 86250), and the current criteria measure how often the disease strikes rather than how bad any single episode felt. Claims are won on the timeline in the medical record, so tracking dates matters as much as tracking pain.

SSA classifies sickle cell disease as a hemolytic anemia, a disorder that destroys red blood cells prematurely. Section 7.00C1 of the Blue Book explains that diagnosis rests on hemoglobin electrophoresis or analysis of red blood cell enzymes and membrane, and Section 7.00B requires a laboratory report of a definitive test, signed by a physician, to document the disorder. Treatment records from a hematologist or a comprehensive sickle cell disease center supply the rest of the evidence.

Documenting Pain Crises Under Listing 7.05, Criterion 1

The first pathway targets the hallmark of the disease, the vaso-occlusive crisis, in which misshapen red cells block small vessels and starve tissue of oxygen. To satisfy it, you need painful crises occurring at least six times within a 12-month period, with at least 30 days between crises. Section 7.00I confirms that events must be at least 30 days apart so that SSA is counting separate episodes.

Two documentation details decide these claims. First, each crisis must be documented in the medical record, which in practice means a provider visit, emergency department record, or treatment note rather than a personal diary alone. Second, each crisis must require parenteral narcotic medication, meaning intravenous or intramuscular treatment, so oral pain medicine managed at home does not fit this criterion. Section 7.00H makes clear that SSA cannot consider symptoms at all without medical signs or laboratory findings showing a medically determinable impairment.

The 12-month window is consecutive, and it can be any 12 consecutive months, all or part of which fall within the period SSA is considering for your application. Crises clustered into a single bad quarter, followed by stability, generally will not add up to six.

Hospitalizations Under Listing 7.05, Criterion 2

The second pathway covers complications of hemolytic anemia requiring at least three hospitalizations within a 12-month period, occurring at least 30 days apart. Each hospitalization must last at least 48 hours, and the count can include hours of emergency treatment received in a hospital emergency department or a comprehensive sickle cell disease center immediately before admission.

Section 7.00C2 lists the complications that commonly force these admissions, and they do not all have to be the same one. Examples include osteomyelitis, painful vaso-occlusive crisis, pulmonary infections or infarctions, acute chest syndrome, pulmonary hypertension, chronic heart failure, gallbladder disease, liver failure, kidney failure, nephrotic syndrome, aplastic crisis, and stroke. A claimant hospitalized once for acute chest syndrome, once for a pain crisis, and once for osteomyelitis has three different complications that still combine under this criterion.

Because the clock runs on admission dates, discharge summaries and billing records that show arrival times in the emergency department can make the difference between a 46-hour stay that fails and a 50-hour stay that counts.

Severe Anemia Under Listing 7.05, Criterion 3

The third pathway turns a simple lab value into a listing-level finding. Hemoglobin measurements of 7.0 grams per deciliter (g/dL) or less must occur at least three times within a 12-month period, with at least 30 days between measurements. Section 7.00C3 states that SSA does not require the blood draws to happen during symptom-free periods, so measurements taken while you are in the middle of a complication, such as an aplastic crisis or a pain episode, are acceptable.

This criterion rewards consistent lab work during acute care. Many patients with sickle cell disease already have frequent hemoglobin checks drawn in emergency departments and infusion centers, and those existing results can be assembled into the required pattern.

Transfusion Dependence Under Listing 7.05, Criterion 4

The fourth pathway covers the most severe form of beta thalassemia major, a related hemoglobinopathy in which the bone marrow cannot produce enough normal red cells to sustain life. It requires life-long red blood cell transfusions at least once every 6 weeks. Section 7.00C4 clarifies that prophylactic transfusions used to prevent strokes in sickle cell disease are not treated as equal to these life-saving transfusions, though their functional impact and side effects, such as iron overload, are considered under Listing 7.18 and the affected body systems.

Beta thalassemia major also appears on SSA's Compassionate Allowances list, which speeds identification of those claims at intake. Sickle cell disease itself is not on that list, so these claims proceed through standard development.

When the Disease Falls Short of 7.05: Listing 7.18

Many claimants have serious, real limitations without hitting the exact event counts. Listing 7.18 covers repeated complications of hematological disorders, including the complications listed in 7.05 but without the requisite findings, or other complications such as anemia, osteonecrosis, retinopathy, skin ulcers, silent central nervous system infarction, cognitive limitation, or limited joint movement. The complications must produce significant documented symptoms or signs, such as pain, severe fatigue, malaise, fever, night sweats, headaches, joint or muscle swelling, or shortness of breath.

The claimant must also show a marked limitation in one of three areas under Section 7.00G: activities of daily living, maintaining social functioning, or completing tasks in a timely manner due to deficiencies in concentration, persistence, or pace. Marked means the symptoms interfere seriously with functioning, and Section 7.00G2 defines repeated complications as occurring on average three times a year, or once every 4 months, each lasting 2 weeks or more, with alternatives for shorter but more frequent, or less frequent but longer, episodes.

Organ Damage in Other Body Systems

Sickle cell disease damages organs over time, and SSA evaluates that damage where it lands. Section 7.00J sends joint deformity to the musculoskeletal listings in 1.00, iron overload from repeated transfusions to the respiratory, cardiovascular, or digestive listings in 3.00, 4.00, and 5.00, and the effects of stroke to the neurological and mental listings in 11.00 and 12.00. Under Section 7.00C4, strokes and their complications in sickle cell disease are evaluated under 11.00 and 12.00 rather than under 7.05.

For a claimant who does not meet or medically equal a listing, SSA assesses residual functional capacity and proceeds through the later steps of the sequential evaluation under 20 CFR 404.1520. Chronic pain, fatigue, and the need for frequent medical care legitimately limit the ability to sustain full-time work.

Non-Medical Requirements in 2026

Eligibility also depends on work history and earnings. Most adults must be insured under 20 CFR 404.130, generally with 20 work credits in the 10 years ending with disability onset, and one credit is earned for each $1,810 of covered wages in 2026, up to four per year. Substantial gainful activity under 20 CFR 404.1574 is capped at $1,690 in average monthly earnings in 2026 for non-blind claimants and $2,830 for claimants who are statutorily blind. The impairment must also satisfy the 12-month duration requirement of 20 CFR 404.1509, which recurrent complications usually satisfy on their own. Application procedures and appeals are governed by separate rules outside the scope of this article.

Frequently Asked Questions

How many pain crises are needed to meet Listing 7.05? SSA requires documented painful vaso-occlusive crises treated with intravenous or intramuscular narcotic medication at least six times within a 12-month period, with at least 30 days between crises.

Do emergency room visits count as hospitalizations under Listing 7.05? Each hospitalization must last at least 48 hours, and hours in a hospital emergency department or a comprehensive sickle cell disease center immediately before admission can count toward that total.

What if sickle cell disease causes severe problems but does not meet Listing 7.05? SSA then considers Listing 7.18, which covers repeated complications combined with a marked limitation in daily activities, social functioning, or completing tasks, and then assesses residual functional capacity.

This article provides general information about SSDI eligibility for sickle cell disease, not legal advice. Program rules, medical listings, and dollar thresholds change over time, and all figures cited here reflect federal standards in effect in 2026. Consult a qualified representative or contact the Social Security Administration directly about your specific claim.